
European Commission solidifies vaccine manufacturing plans to prepare for future health emergencies
The European Commission struck deals with a handful of contractors, including Pfizer, to secure “sufficient and agile manufacturing capacities” for a variety of vaccine types in case of future public health emergencies.
The contracts are part of the commission’s long-standing goal to create a network of “ever-warm production capacities” for vaccine and drug manufacturing in Europe. They were first reported by Reuters. Under the framework, the EC’s European Health and Digital Executive Agency would have access up to 325 million vaccine doses per year, it announced Friday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.